African swine fever (ASF) is a highly contagious and lethal hemorrhagic disease affecting domestic pigs and wild boars, often resulting in mortality rates approaching 100% in infected domestic pigs . The African swine fever virus (ASFV) is a large, complex DNA virus that replicates in the cytoplasm of infected cells . Due to the devastating impact of ASF on the global pig industry, there is a critical need to understand the virus's mechanisms and develop effective vaccines and antiviral strategies .
Recombinant African swine fever virus Cysteine-rich protein E199L (War-140), also referred to as pE199L, is a viral protein that has garnered significant attention for its role in virus entry and its potential as a target for therapeutic intervention .
Recombinant ASFV Cysteine-rich protein E199L (War-140) is a cysteine-rich structural polypeptide. It shows similarities to proteins A16, G9, and J5 of the entry fusion complex (EFC) of poxviruses . Key characteristics include:
Source: The E199L protein is derived from the African swine fever virus, specifically isolate Warthog/Namibia/Wart80/1980 . Recombinant versions of the protein are often produced in E. coli .
Molecular Weight: The protein sequence corresponds to a full-length protein of 200 amino acids .
Localization: pE199L localizes to the inner viral envelope and behaves as an integral transmembrane polypeptide with cytosolic intramolecular disulfide bonds .
The pE199L protein is crucial for the African swine fever virus during the early stages of infection. Research indicates that pE199L is essential for membrane fusion and core penetration during viral entry . Specifically, pE199L is required for the fusion event that allows the viral genome to penetrate the host cell .
Studies using ASFV recombinants have shown that while pE199L is not required for virus assembly, egress, virus-cell binding or endocytosis, it plays a vital role in the membrane fusion process . This indicates that ASFV entry relies on a fusion mechanism involving pE199L and pE248R, showing similarities to the fusion apparatus seen in poxviruses .
Several studies have focused on the functional characterization of pE199L and its potential as a target for antiviral strategies.
Inhibition of Type I Interferon (IFN) Production: The ASFV H240R protein (pH240R), a capsid protein, was found to inhibit type I IFN production. This suggests that suppressing host innate immune responses is linked to viral pathogenicity. Deletion of the H240R gene reduces viral pathogenicity by enhancing type I IFN production, which decreases ASFV replication .
Interaction with Host Proteins: ASFV protein CP204L interacts with the cellular homotypic fusion and protein sorting (HOPS) protein VPS39, which affects endolysosomal trafficking and promotes lysosome clustering. The interaction between CP204L and VPS39 modulates host membrane rearrangement during infection. Loss of VPS39 reduces the levels of virus proteins synthesized in the early phase of infection and delays ASFV replication .
The identification of ASFV genes related to virulence and pathogenicity is crucial for developing live attenuated vaccines . E199L is a potential target for the development of strategies that block the early stages of ASFV replication . Some studies have explored the use of virally vectored African swine fever antigens, including E183L and CP204L, to induce protective immunity in pigs .
| Feature | Description |
|---|---|
| Protein Name | Cysteine-rich protein E199L (War-140) |
| Alternative Name | pE199L |
| Virus Isolate | Warthog/Namibia/Wart80/1980 |
| Origin | African swine fever virus (ASFV) |
| Function | Mediates virus entry by facilitating membrane fusion and core penetration |
| Similarity | Shows similarity to poxvirus proteins A16, G9, and J5 |
| Localization | Inner viral envelope |
| Involvement in Virus Assembly | Not required for virus assembly or egress |
| Potential Applications | Target for antiviral strategies, vaccine development |
E199L is a cysteine-rich structural polypeptide that functions as an integral transmembrane protein located in the inner viral envelope of African swine fever virus. The protein contains intramolecular disulfide bonds on the cytosolic side and shares structural similarities with proteins A16, G9, and J5 of the entry fusion complex (EFC) in poxviruses . The cysteine-rich nature of E199L suggests a role in maintaining structural integrity through disulfide bond formation, which is crucial for proper protein function during viral entry processes.
During viral assembly, E199L becomes incorporated into the inner viral membrane, as confirmed through biochemical and immunomicroscopic approaches . When virions are purified and analyzed through Percoll density gradients, E199L consistently localizes with inner membrane components rather than with outer envelope or core proteins. This localization is critical for its function in membrane fusion events during viral entry. Experimentally, this localization can be verified using immunofluorescence microscopy with antibodies against E199L alongside markers for different viral structural layers.
E199L operates as an essential component of ASFV's fusion machinery alongside protein pE248R. Experimental evidence using an inducible recombinant virus (vE199Li) demonstrates that viral particles lacking E199L (vE199Li-) are unable to initiate infection despite normal endocytosis . Specifically, E199L facilitates the fusion between the virus inner membrane and the limiting membrane of late endosomes, which is required for delivering the genome-containing core into the host cell cytoplasm. Without E199L, the proportion of naked viral cores in the cytoplasm is reduced by more than 12-fold in both Vero cells and swine macrophages, as quantified through immunofluorescence microscopy using antibodies against viral inner membrane protein p12 and core component p150 .
To differentiate between E199L's roles in viral attachment and membrane fusion, researchers can employ multiple complementary techniques:
Binding assays with purified virions (vE199Li+ vs. vE199Li-) at 4°C to assess attachment capacity
Endocytosis tracking using fluorescently labeled virions with confocal microscopy
Fusion assays using labeled viral and endosomal membranes to detect mixing of lipids
Core penetration assays using immunofluorescence microscopy with antibodies against core proteins (p150) and membrane proteins (p12)
Research has demonstrated that E199L is specifically required for membrane fusion and core penetration, not for virus assembly, egress, binding to cells, or endocytosis . This methodological approach allows researchers to pinpoint the precise stage of viral entry that requires E199L function.
For generating high-specificity antibodies against E199L, recombinant protein expression in bacterial systems has proven effective. The methodology involves:
Cloning the E199L ORF into an expression vector (e.g., pRSETA)
Expressing the protein in Escherichia coli
Isolating inclusion bodies containing recombinant E199L
Separating proteins using 12% polyacrylamide gel electrophoresis
Excising the E199L band for immunization
This approach has successfully generated polyclonal antibodies in rats with high specificity for E199L detection in various applications including Western blotting, immunofluorescence, and immunoprecipitation . For optimal results, researchers should consider using the full-length protein rather than peptides to ensure detection of conformational epitopes.
For essential viral proteins like E199L, conditional expression systems provide valuable tools for functional studies. A proven methodology involves:
Generating inducible recombinant viruses (e.g., vE199Li) by replacing the native gene promoter with an IPTG-dependent promoter
Inserting a repressor gene (e.g., lacI) under a constitutive promoter
Growing the virus under permissive conditions (with inducer) for stock preparation
Conducting comparative analyses under permissive and non-permissive conditions
This system allows researchers to:
Produce viral particles lacking E199L for functional studies
Perform one-step growth curve analyses to quantify the impact on viral replication
Compare plaque formation between wild-type and conditional mutants
Analyze the biochemical composition of defective particles
Using this approach, researchers have demonstrated that E199L is essential for ASFV replication, with virus titers reduced by more than 2.0 log units at 48 hours post-infection under non-permissive conditions .
E199L induces a complete autophagy process in host cells through its interaction with Pyrroline-5-carboxylate reductase 2 (PYCR2). The molecular mechanism involves:
Direct binding between E199L and PYCR2, confirmed through co-immunoprecipitation coupled with mass spectrometry (CoIP-MS)
E199L-mediated downregulation of PYCR2 expression levels
Reduction in PYCR2 activity, which normally converts glutamate to proline
Activation of autophagy signaling pathways in response to altered PYCR2 levels
This process has been validated in both Vero and HEK-293T cells, suggesting a conserved mechanism across different cell types . The autophagy induction can be monitored using standard markers like LC3-II conversion, p62 degradation, and autophagosome formation through fluorescence microscopy.
To differentiate E199L-induced autophagy from other forms, researchers should implement a multi-faceted approach:
Genetic verification: Using E199L knockout/knockdown systems compared to wild-type infections
Molecular pathway analysis: Examining PYCR2 levels and activity in E199L-expressing versus control cells
Pharmacological intervention: Testing whether PYCR2 supplementation or proline addition can reverse E199L-induced autophagy
Temporal assessment: Monitoring the kinetics of autophagy induction in relation to E199L expression
Comparative analysis: Using other autophagy inducers (rapamycin, starvation) alongside E199L expression
Through these approaches, researchers can establish the specific characteristics of E199L-induced autophagy, distinguishing it from canonical autophagy pathways or autophagy induced by other viral proteins.
E199L's dual roles in viral entry and autophagy regulation present multiple intervention opportunities:
Entry inhibition strategies:
Developing peptide inhibitors targeting the fusion domain of E199L
Designing small molecules that disrupt E199L-mediated membrane fusion
Creating antibodies that neutralize E199L function during viral entry
Autophagy modulation approaches:
Targeting the E199L-PYCR2 interaction to prevent autophagy manipulation
Developing compounds that restore PYCR2 levels during infection
Exploiting E199L-induced autophagy to promote viral clearance
Since E199L is essential for virus replication, with conditional knockouts showing >99% reduction in viral titers , it represents a high-value target for antiviral development. Additionally, understanding how E199L modulates autophagy could reveal insights into viral evasion of host defenses and inform broader antiviral strategies.
For evaluating E199L inhibitors, a multi-tiered experimental approach is recommended:
In vitro binding assays:
Surface plasmon resonance (SPR) to assess direct binding of compounds to E199L
Thermal shift assays to evaluate compound effects on E199L stability
Cellular infection models:
Vero cells and porcine macrophages for initial screening
Primary porcine alveolar macrophages for physiologically relevant testing
Conditional E199L mutant viruses (vE199Li) as controls
Functional assays:
Membrane fusion assays to directly measure inhibition of E199L's fusion activity
Immunofluorescence microscopy to quantify core penetration in the presence of inhibitors
Autophagy assessment through LC3-II conversion and autophagosome formation
Mechanistic validation:
Co-immunoprecipitation to verify disruption of E199L-PYCR2 interaction
Structural studies (X-ray crystallography or cryo-EM) to confirm binding modes
This comprehensive approach would enable researchers to identify and validate E199L inhibitors with potential for development as antiviral therapeutics.
E199L sequence conservation and variation analysis across ASFV genotypes provides important insights into structure-function relationships. While specific data on E199L variation across all 24 p72 genotypes is not completely detailed in the provided references, recent detection of recombinant ASFV strains involving genotypes I and II in Vietnam raises important questions about E199L conservation.
Researchers should consider:
Performing comparative sequence analysis of E199L across genotypes I and II
Examining whether recombination events affect the E199L coding region
Assessing if E199L sequence variations correlate with changes in viral tropism, fusion efficiency, or autophagy induction
Investigating whether E199L polymorphisms contribute to immune evasion or altered virulence
Understanding these variations could help explain differences in virulence between ASFV strains and inform the development of broadly effective countermeasures.
For detecting and characterizing recombination events affecting E199L, researchers should implement a comprehensive genomic analysis approach:
Whole genome sequencing:
Next-generation sequencing of multiple isolates from different geographical regions
Deep sequencing to identify minor variants within viral populations
Recombination detection algorithms:
RDP4 software suite implementing multiple detection methods
SimPlot and Bootscan analyses to visualize potential recombination breakpoints
Maximum likelihood phylogenetic analyses of sequence segments
Functional validation:
Generation of chimeric E199L proteins based on detected recombination patterns
Testing fusion activity and PYCR2 interaction of recombinant E199L variants
Assessing virulence and replication efficiency of reconstructed recombinants
Evolutionary analyses:
Selection pressure analysis (dN/dS ratios) on the E199L gene
Bayesian phylogenetic approaches to date recombination events
Population genetic analyses to assess the spread of recombinant variants
Given the recent detection of recombinant ASFV strains in Vietnam involving genotypes I and II , surveillance for E199L recombinants should be prioritized to understand potential impacts on viral entry mechanics and autophagy regulation.